A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory multiple myeloma (CAMMOUFLAGE trial).

被引：0
|
作者：
Berdeja, Jesus G.
Martin, Thomas G.
Rossi, Adriana
Essell, James H.
Siegel, David Samuel DiCapua
Mailankody, Sham
Saini, Neeraj
Holmes, Houston
Dhakal, Binod
Gasparetto, Cristina J.
Parekh, Samir S.
Portella, Socorro
Ledergor, Guy
Hammad, Ashley
Davi, Franco
Skoble, Justin
Garner, Elizabeth
Kanner, Steven Brian
Rizvi, Syed
Jagannath, Sundar
机构：
[1] Sarah Cannon Res Inst, Nashville, TN USA
[2] Univ Calif San Francisco, Dept Hematol, San Francisco, CA USA
[3] Icahn Sch Med Mt Sinai, New York, NY USA
[4] Onc Hem Care Inc, Cincinnati, OH USA
[5] Hackensack Meridian Hlth, Ctr Discovery & Innovat, Nutley, NJ USA
[6] Mem Sloan Kettering Canc Ctr, New York, NY USA
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[8] Texas Oncol, Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
[9] Med Coll Wisconsin, Milwaukee, WI USA
[10] Duke Univ, Inst Canc, Dept Med, Durham, NC USA
[11] Caribou Biosci, Berkeley, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS8063
引用
收藏
页数：1
相关论文
共 23 条
  • [1] A first-in-human phase 1, multicenter, open-label study of CB-012, a next-generation CRISPR-edited allogeneic anti-CLL-1 CAR-T cell therapy for adults with relapsed/refractory acute myeloid leukemia (AMpLify).
    Daver, Naval Guastad
    Maiti, Abhishek
    Sallman, David Andrew
    Roboz, Gail J.
    Solh, Melhem M.
    Milano, Filippo
    Strickland, Stephen Anthony
    Eghtedar, Alireza
    Kanner, Steven Brian
    Ledergor, Guy
    Marcy, Donna
    Garner, Elizabeth
    Francica, Brian J.
    Shaw, Mckay
    Bird, Kalin
    Rattan, Jennifer
    Zudaire, Enrique
    Portella, Socorro
    Vachhani, Pankit
    Park, Jae H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] A First-in-Human Phase 1, Multicenter, Open-Label Study of CB-010, a Next-Generation CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy with a PD-1 Knockout, in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER Study)
    O'Brien, Susan
    Nastoupil, Loretta J.
    Essell, James
    Dsouza, Ly
    Hart, Doug
    Matsuda, Emiri
    Satterfield, Tarah
    Nesheiwat, Tonia
    Hammad, Ashley
    Davi, Franco
    Chung, Shally
    Shamsi, S. Asim
    Bryan, Mara
    Skoble, Justin
    Garner, Elizabeth
    Kanner, Steven
    Rizvi, Syed
    Holmes, Houston
    BLOOD, 2022, 140 : 9457 - 9458
  • [3] FIRST-IN-HUMAN MULTICENTER STUDY OF BB2121 ANTI-BCMA CAR T CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS
    Lin, Y.
    Berdeja, J.
    Raje, N.
    Munshi, N.
    Siegel, D.
    Liedtke, M.
    Jagannath, S.
    Maus, M.
    Turka, A.
    Lam, L. P.
    Hege, K.
    Morgan, R.
    Quigley, M. T.
    Kochenderfer, J.
    HAEMATOLOGICA, 2017, 102 : 21 - 21
  • [4] First-in-human multicenter study of bb2121 anti-BCMA CAR T-cell therapy for relapsed/refractory multiple myeloma: Updated results.
    Berdeja, Jesus G.
    Lin, Yi
    Raje, Noopur S.
    Siegel, David Samuel DiCapua
    Munshi, Nikhil C.
    Liedtke, Michaela
    Jagannath, Sundar
    Maus, Marcela Valderrama
    Turka, Ashley
    Lam, Lyh Ping
    Hege, Kristen
    Morgan, Richard
    Quigley, M. Travis
    Kochenderfer, James
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] The interim analysis of a first-in-human phase 1 trial of ET-901, a CRISPR edited allogeneic immune-cloaked anti-CD19 CAR-T cell therapy in patients with r/r B-NHL
    Liu, Yang
    Shi, Jinhong
    Yang, Qingming
    Wang, Chunmeng
    Liang, Feifei
    Wu, Zeguang
    Lamao, Qiezhong
    Yang, Jinxin
    Qiu, Yuanyuan
    Tang, Wei
    Zhang, Haixia
    Yang, Zhonghan
    Yang, Ling
    Zhang, Yongjian
    Jin, Ming
    Yuan, Pengfei
    Wei, Wensheng
    Han, Weidong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Clinical remissions and limited toxicity in a first-in-human multicenter study of bb2121, a novel anti-BCMA CAR T cell therapy for relapsed/refractory multiple myeloma
    Berdeja, J. G.
    Lin, Y.
    Raje, N.
    Siegel, D.
    Munshi, N.
    Turka, A.
    Lam, L. P.
    Quigley, M. T.
    Kochenderfer, J. N.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S5 - S5
  • [7] A phase 1 multicenter study evaluating KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma.
    Cornell, Robert F.
    Locke, Frederick Lundry
    Bishop, Michael Russell
    Orlowski, Robert Z.
    Larson, Sarah Marie
    Borrello, Ivan
    Giralt, Sergio
    Kumar, Shaji
    Nooka, Ajay K.
    Raje, Noopur S.
    Rossi, John M.
    Thomrongsith, Lisa
    Xue, Allen
    Roberts, Zachary
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Phase 2, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-BCMA CAR-T Cell Therapy, in Chinese Patients with Relapsed/Refractory Multiple Myeloma (CARTIFAN-1): 26-Month Median Follow-up
    Mi, Jian-Qing
    Zhao, Wanhong
    Jing, Hongmei
    Fu, Weijun
    Hu, Jianda
    Chen, Lijuan
    Zhang, Yiwen
    Yao, Dan
    Li, Hui
    Schecter, Jordan M.
    Yang, Fan
    Sun, Huabin
    Zhuang, Sen Hong
    Xu, Da
    Luo, Tracy
    Fan, Xiaohu
    Niu, Ting
    Jin, Jie
    Chen, Sai-Juan
    BLOOD, 2022, 140 : 7542 - 7544
  • [9] A phase 1, multicenter study evaluating the safety and efficacy of KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma
    Cornell, Robert F.
    Bishop, Michael R.
    Kumar, Shaji
    Giralt, Sergio A.
    Nooka, Ajay K.
    Larson, Sarah M.
    Locke, Frederick L.
    Raje, Noopur S.
    Lei, Lei
    Dong, Jinghui
    Gall, John B. Le
    Rossi, John M.
    Orlowski, Robert Z.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 3285 - 3293
  • [10] Clinical Results of a Multicenter Study of the First-in-Human Dual BCMA and CD19 Targeted Novel Platform Fast CAR-T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma
    Jiang, Hua
    Dong, Baoxia
    Gao, Li
    Liu, Li
    Ge, Jian
    He, Aili
    Du, Juan, Jr.
    Chen, Xiequn
    Zhao, Yi
    Han, Yu
    Chen, Yuezhang
    Xu, Yuesheng
    Zhang, Hua
    He, Jiaping
    Shi, Huan
    Han, Cong
    Ye, Xun
    Wang, Zhenguang
    Liu, Jia
    Shen, Lianjun
    Cao, Wei
    Sersch, Martina
    Fu, Weijun
    BLOOD, 2020, 136
123